Safety and Immunogenicity of Novel Adenovirus Type 26– and Modified Vaccinia Ankara–Vectored Ebola Vaccines-Reference-Cited by-同舟云学术

Safety and Immunogenicity of Novel Adenovirus Type 26– and Modified Vaccinia Ankara–Vectored Ebola Vaccines

Published:2016-04-19 Issue:15 Volume:315 Page:1610
ISSN:0098-7484
Container-title:JAMA
language:en
Short-container-title:JAMA

Author:

Milligan Iain D.¹,Gibani Malick M.¹,Sewell Richard¹,Clutterbuck Elizabeth A.¹,Campbell Danielle¹,Plested Emma¹,Nuthall Elizabeth¹,Voysey Merryn²,Silva-Reyes Laura¹,McElrath M. Juliana³,De Rosa Stephen C.³,Frahm Nicole³,Cohen Kristen W.³,Shukarev Georgi⁴,Orzabal Nicola⁴,van Duijnhoven Wilbert⁴,Truyers Carla⁴,Bachmayer Nora⁴,Splinter Daniel⁴,Samy Nathaly⁵,Pau Maria Grazia⁴,Schuitemaker Hanneke⁴,Luhn Kerstin⁴,Callendret Benoit⁴,Van Hoof Johan⁴,Douoguih Macaya⁴,Ewer Katie⁶,Angus Brian⁷,Pollard Andrew J.⁸,Snape Matthew D.⁸

Affiliation:

1. Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom

2. Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom2Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom

3. Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington

4. Janssen, Pharmaceutical Companies of Johnson & Johnson, Leiden, the Netherlands

5. Bavarian Nordic, Martinsried, Germany

6. Jenner Institute, Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford, Oxford, United Kingdom7National Institute for Health Research (NIHR) Oxford Biomedical Research Centre, Oxford, United Kingdom

7. Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom

8. Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom7National Institute for Health Research (NIHR) Oxford Biomedical Research Centre, Oxford, United Kingdom

Publisher

American Medical Association (AMA)

Subject

General Medicine

Cited by 278 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent Advances in Therapeutic Approaches Against Ebola Virus Infection;Recent Advances in Anti-Infective Drug Discovery;2024-11

2. Longitudinal multiomic profiling and corticosteroid modulation of the immediate innate immune response to an adenovirus-vector vaccine;Vaccine;2024-11

3. Long-term cellular immunity of vaccines for Zaire Ebola Virus Diseases;Nature Communications;2024-09-03

4. A pseudotyped adenovirus serotype 5 vector with serotype 49 fiber knob is an effective vector for vaccine and gene therapy applications;Molecular Therapy - Methods & Clinical Development;2024-09

5. A quadrivalent norovirus vaccine based on a chimpanzee adenovirus vector induces potent immunity in mice;Virologica Sinica;2024-08